Plexus Corp. (NASDAQ:PLXS) CEO Sells $659,320.00 in Stock

Plexus Corp. (NASDAQ:PLXS) CEO Todd P. Kelsey sold 4,000 shares of the stock in a transaction dated Wednesday, November 6th. The shares were sold at an average price of $164.83, for a total value of $659,320.00. Following the completion of the sale, the chief executive officer now directly owns 77,026 shares in the company, valued at $12,696,195.58. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website.

Plexus Stock Up 10.0 %

Shares of NASDAQ PLXS traded up $15.15 during mid-day trading on Wednesday, reaching $166.77. The company had a trading volume of 369,609 shares, compared to its average volume of 131,517. Plexus Corp. has a 52-week low of $90.18 and a 52-week high of $169.41. The stock has a market cap of $4.54 billion, a P/E ratio of 41.74 and a beta of 0.87. The company has a current ratio of 1.51, a quick ratio of 0.71 and a debt-to-equity ratio of 0.07. The firm has a 50 day simple moving average of $133.72 and a two-hundred day simple moving average of $118.96.

Plexus (NASDAQ:PLXS) last posted its earnings results on Wednesday, October 23rd. The technology company reported $1.85 EPS for the quarter, topping analysts’ consensus estimates of $1.55 by $0.30. The business had revenue of $1.05 billion for the quarter, compared to analysts’ expectations of $1.01 billion. Plexus had a return on equity of 9.51% and a net margin of 2.82%. The business’s revenue was up 2.6% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.44 earnings per share. Sell-side analysts predict that Plexus Corp. will post 6.2 earnings per share for the current year.

Analyst Ratings Changes

PLXS has been the subject of a number of recent research reports. Needham & Company LLC lifted their price target on shares of Plexus from $144.00 to $162.00 and gave the stock a “buy” rating in a research note on Friday, October 25th. StockNews.com cut shares of Plexus from a “buy” rating to a “hold” rating in a research report on Wednesday. Benchmark increased their target price on Plexus from $150.00 to $165.00 and gave the company a “buy” rating in a report on Monday, October 28th. Finally, KeyCorp began coverage on Plexus in a report on Tuesday, October 22nd. They set a “sector weight” rating for the company. Four analysts have rated the stock with a hold rating and two have issued a buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $133.50.

Institutional Investors Weigh In On Plexus

Large investors have recently modified their holdings of the company. Quest Partners LLC raised its position in Plexus by 36,700.0% in the 2nd quarter. Quest Partners LLC now owns 368 shares of the technology company’s stock valued at $38,000 after purchasing an additional 367 shares during the last quarter. Farther Finance Advisors LLC increased its stake in Plexus by 89.4% in the third quarter. Farther Finance Advisors LLC now owns 464 shares of the technology company’s stock valued at $63,000 after purchasing an additional 219 shares during the period. Innealta Capital LLC purchased a new stake in shares of Plexus in the second quarter valued at about $51,000. GAMMA Investing LLC boosted its stake in shares of Plexus by 190.1% during the third quarter. GAMMA Investing LLC now owns 760 shares of the technology company’s stock worth $104,000 after buying an additional 498 shares during the period. Finally, EntryPoint Capital LLC grew its holdings in shares of Plexus by 56.2% during the first quarter. EntryPoint Capital LLC now owns 976 shares of the technology company’s stock worth $93,000 after buying an additional 351 shares during the last quarter. 94.45% of the stock is owned by institutional investors and hedge funds.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.